News

Search here results

• Edward Showler Foundation and UCL partner to accelerate research into clear cell sarcoma | UCL Cancer Institute - UCL – University College London
• Professor Mark Emberton awarded OBE in Queen’s Birthday Honours | UCL Faculty of Medical Sciences - UCL – University College London
• Combination immunotherapy for metastatic prostate cancer shows promise | UCL Cancer Institute - UCL – University College London
• Cells from the centre of tumours most likely to spread around the body | UCL Cancer Institute - UCL – University College London
• Spotlight: Capturing images of 'Dancing DNA' | UCL Cancer Institute - UCL – University College London
• From lab to clinic: Redefining CD25 as an immunotherapy drug target | UCL Cancer Institute - UCL – University College London
• UCL spinout Achilles Therapeutics raises $175.5m to develop new immunotherapies | UCL Cancer Institute - UCL – University College London
• Research into childhood cancers awarded innovation funding | UCL Cancer Institute - UCL – University College London
• Cancer in a time of COVID – keeping vital research and treatment on track | UCL Cancer Institute - UCL – University College London
• Genetic changes in tumours could help predict if patients will respond to immunotherapy | UCL Cancer Institute - UCL – University College London